Probiotics in prevention of surgical site infections

Ragavan Siddharthan, Michael Chapek, Malissa Warren, Robert Martindale

Research output: Contribution to journalArticle

Abstract

Despite significant improvements in peri-operative care, surgical site infections (SSIs) remain an important contributor to morbidity, cost, and death. The human gastrointestinal tract is a complex microenvironment linking host cells and the indigenous microflora or "microbiome," creating a "super-organism" that engages in macro-nutrient and micro-nutrient extraction for the host while serving as a barrier to toxins and other detrimental bacterial end-products. Maintaining a healthy microbiome in the peri-operative period may enable control of multi-drug resistance (MDR) organisms, whereas use of antibiotics simply resets the dysbiotic relation by eliminating multiple strains of bacteria. Such loss of microbial diversity or abundance can slow wound healing. Use of pro-biotics to prevent infection has been evaluated in several studies, but their utility is not yet clear. There is a clear need for randomized trials to draw firm conclusions about their efficacy and to make clinical recommendations.

Original languageEnglish (US)
Pages (from-to)831-835
Number of pages5
JournalSurgical Infections
Volume19
Issue number8
DOIs
StatePublished - Nov 1 2018

Fingerprint

Surgical Wound Infection
Microbiota
Probiotics
Food
Multiple Drug Resistance
Wound Healing
Gastrointestinal Tract
Anti-Bacterial Agents
Morbidity
Bacteria
Costs and Cost Analysis
Infection

Keywords

  • microbiome
  • multi-drug resistant organisms
  • probiotics
  • surgical site infections

ASJC Scopus subject areas

  • Surgery
  • Microbiology (medical)
  • Infectious Diseases

Cite this

Probiotics in prevention of surgical site infections. / Siddharthan, Ragavan; Chapek, Michael; Warren, Malissa; Martindale, Robert.

In: Surgical Infections, Vol. 19, No. 8, 01.11.2018, p. 831-835.

Research output: Contribution to journalArticle

Siddharthan, Ragavan ; Chapek, Michael ; Warren, Malissa ; Martindale, Robert. / Probiotics in prevention of surgical site infections. In: Surgical Infections. 2018 ; Vol. 19, No. 8. pp. 831-835.
@article{7181de6091a64d8cb8ec7296f138545f,
title = "Probiotics in prevention of surgical site infections",
abstract = "Despite significant improvements in peri-operative care, surgical site infections (SSIs) remain an important contributor to morbidity, cost, and death. The human gastrointestinal tract is a complex microenvironment linking host cells and the indigenous microflora or {"}microbiome,{"} creating a {"}super-organism{"} that engages in macro-nutrient and micro-nutrient extraction for the host while serving as a barrier to toxins and other detrimental bacterial end-products. Maintaining a healthy microbiome in the peri-operative period may enable control of multi-drug resistance (MDR) organisms, whereas use of antibiotics simply resets the dysbiotic relation by eliminating multiple strains of bacteria. Such loss of microbial diversity or abundance can slow wound healing. Use of pro-biotics to prevent infection has been evaluated in several studies, but their utility is not yet clear. There is a clear need for randomized trials to draw firm conclusions about their efficacy and to make clinical recommendations.",
keywords = "microbiome, multi-drug resistant organisms, probiotics, surgical site infections",
author = "Ragavan Siddharthan and Michael Chapek and Malissa Warren and Robert Martindale",
year = "2018",
month = "11",
day = "1",
doi = "10.1089/sur.2018.231",
language = "English (US)",
volume = "19",
pages = "831--835",
journal = "Surgical Infections",
issn = "1096-2964",
publisher = "Mary Ann Liebert Inc.",
number = "8",

}

TY - JOUR

T1 - Probiotics in prevention of surgical site infections

AU - Siddharthan, Ragavan

AU - Chapek, Michael

AU - Warren, Malissa

AU - Martindale, Robert

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Despite significant improvements in peri-operative care, surgical site infections (SSIs) remain an important contributor to morbidity, cost, and death. The human gastrointestinal tract is a complex microenvironment linking host cells and the indigenous microflora or "microbiome," creating a "super-organism" that engages in macro-nutrient and micro-nutrient extraction for the host while serving as a barrier to toxins and other detrimental bacterial end-products. Maintaining a healthy microbiome in the peri-operative period may enable control of multi-drug resistance (MDR) organisms, whereas use of antibiotics simply resets the dysbiotic relation by eliminating multiple strains of bacteria. Such loss of microbial diversity or abundance can slow wound healing. Use of pro-biotics to prevent infection has been evaluated in several studies, but their utility is not yet clear. There is a clear need for randomized trials to draw firm conclusions about their efficacy and to make clinical recommendations.

AB - Despite significant improvements in peri-operative care, surgical site infections (SSIs) remain an important contributor to morbidity, cost, and death. The human gastrointestinal tract is a complex microenvironment linking host cells and the indigenous microflora or "microbiome," creating a "super-organism" that engages in macro-nutrient and micro-nutrient extraction for the host while serving as a barrier to toxins and other detrimental bacterial end-products. Maintaining a healthy microbiome in the peri-operative period may enable control of multi-drug resistance (MDR) organisms, whereas use of antibiotics simply resets the dysbiotic relation by eliminating multiple strains of bacteria. Such loss of microbial diversity or abundance can slow wound healing. Use of pro-biotics to prevent infection has been evaluated in several studies, but their utility is not yet clear. There is a clear need for randomized trials to draw firm conclusions about their efficacy and to make clinical recommendations.

KW - microbiome

KW - multi-drug resistant organisms

KW - probiotics

KW - surgical site infections

UR - http://www.scopus.com/inward/record.url?scp=85058385613&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058385613&partnerID=8YFLogxK

U2 - 10.1089/sur.2018.231

DO - 10.1089/sur.2018.231

M3 - Article

VL - 19

SP - 831

EP - 835

JO - Surgical Infections

JF - Surgical Infections

SN - 1096-2964

IS - 8

ER -